Find information on Panic Disorder with Agoraphobia diagnosis, including clinical documentation, medical coding (ICD-10 F41.01, DSM-5 300.22), differential diagnosis, treatment, and management. This resource covers healthcare professional guidelines for accurate panic attack symptom identification, agoraphobia severity assessment, and best practices for patient care. Learn about panic disorder criteria, agoraphobic avoidance behaviors, and evidence-based treatment options for effective intervention and improved patient outcomes.
Also known as
Panic disorder agoraphobia
Panic disorder with agoraphobia.
Agoraphobia
Fear of open spaces or situations where escape is difficult.
Other specified anxiety disorders
Includes anxiety disorders not classified elsewhere.
Anxiety disorder unspecified
Generalized anxiety not meeting specific criteria.
Follow this step-by-step guide to choose the correct ICD-10 code.
Panic disorder and agoraphobia both present?
When to use each related code
| Description |
|---|
| Panic attacks with fear of escape difficulty |
| Panic attacks without agoraphobia |
| Fear of specific objects or situations |
Incorrectly coding agoraphobia without panic disorder (F40.00) when panic disorder is present (F41.0), leading to underreporting of severity.
Lack of documentation specifying panic disorder type (e.g., unexpected, nocturnal) may lead to coding errors and affect severity-based reimbursement.
Miscoding other anxiety disorders or depressive disorders as panic disorder with agoraphobia due to overlapping symptoms, impacting accurate diagnosis tracking.
Q: How to differentiate Panic Disorder with Agoraphobia from other anxiety disorders in clinical practice using DSM-5 criteria?
A: Differentiating Panic Disorder with Agoraphobia from other anxiety disorders requires careful consideration of the DSM-5 criteria. Panic Disorder is characterized by recurrent unexpected panic attacks and at least one month of persistent concern or worry about additional panic attacks or their consequences. Agoraphobia, often comorbid, involves marked fear or anxiety about two or more of five situations: using public transportation, being in open spaces, being in enclosed spaces, standing in line or being in a crowd, and being outside of the home alone. The key distinction lies in the trigger for the anxiety. In Panic Disorder, the anxiety revolves around the possibility of having a panic attack. In contrast, with specific phobias or social anxiety disorder, the anxiety is specific to the phobic object or social situation. Generalized Anxiety Disorder, while involving excessive worry, lacks the defining panic attacks and agoraphobic avoidance behaviors. For a comprehensive differential diagnosis, clinicians should carefully assess the onset, frequency, and context of anxiety symptoms, alongside any avoidance behaviors. Explore how structured clinical interviews can aid in this process and consider implementing standardized anxiety assessment tools for a more precise diagnosis. Learn more about validated questionnaires to support diagnostic decision-making.
Q: What are the most effective evidence-based treatment options for co-occurring Panic Disorder and Agoraphobia in adults, and how can treatment resistance be addressed?
A: Cognitive Behavioral Therapy (CBT) and Selective Serotonin Reuptake Inhibitors (SSRIs) are generally considered first-line treatments for co-occurring Panic Disorder and Agoraphobia in adults. CBT helps patients identify and modify maladaptive thoughts and behaviors related to panic and agoraphobia, while SSRIs can help manage the physiological symptoms of anxiety. Combining CBT and medication is often more effective than either treatment alone. Treatment resistance, characterized by a lack of significant improvement despite adequate treatment, can be addressed by considering several factors. These include comorbid conditions, inadequate treatment duration or intensity, non-adherence to treatment, and the presence of specific psychological factors like avoidance behaviors or safety-seeking behaviors. Consider implementing strategies like increasing medication dosage, switching to a different SSRI or an alternative class of medication, augmenting with other medications, intensifying CBT, or exploring other evidence-based therapies like exposure therapy or acceptance and commitment therapy (ACT). Learn more about personalized treatment approaches and strategies for enhancing treatment adherence.
Patient presents with symptoms consistent with Panic Disorder with Agoraphobia (DSM-5 300.01 F41.0). The patient reports recurrent unexpected panic attacks, characterized by intense fear, palpitations, sweating, trembling, shortness of breath, chest pain, nausea, dizziness, derealization, fear of losing control, and fear of dying. These panic attacks are followed by persistent concern about additional attacks and their implications, as well as a significant maladaptive change in behavior related to the attacks. The patient exhibits marked anxiety about two or more situations including using public transportation, being in open spaces, being in enclosed places, standing in line or being in a crowd, and being outside of the home alone. These situations are avoided or endured with marked distress or anxiety due to fear of experiencing panic-like symptoms or other incapacitating or embarrassing symptoms. The patient's avoidance behaviors significantly restrict their daily activities, occupational functioning, and social engagements. Differential diagnoses considered include generalized anxiety disorder, social anxiety disorder, specific phobias, and medical conditions such as hyperthyroidism and cardiac arrhythmias. Current medications include none. Assessment reveals significant impairment in social and occupational functioning due to agoraphobic avoidance. Treatment plan includes initiation of cognitive behavioral therapy (CBT) focusing on panic control techniques, exposure therapy for agoraphobia, and psychoeducation regarding panic disorder and its management. The patient will be monitored for symptom reduction, improvement in functional capacity, and medication needs. Follow-up appointments are scheduled bi-weekly to assess treatment progress and adjust the treatment plan as needed. ICD-10 code F41.0 and CPT codes 90837 for psychotherapy are relevant for billing and coding purposes. Prognosis is guarded but favorable with consistent adherence to the treatment plan.